Your browser doesn't support javascript.
loading
Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects.
Laskowski, Tamara J; Van Caeneghem, Yasmine; Pourebrahim, Rasoul; Ma, Chao; Ni, Zhenya; Garate, Zita; Crane, Ana M; Li, Xuan Shirley; Liao, Wei; Gonzalez-Garay, Manuel; Segovia, Jose Carlos; Paschon, David E; Rebar, Edward J; Holmes, Michael C; Kaufman, Dan; Vandekerckhove, Bart; Davis, Brian R.
Afiliação
  • Laskowski TJ; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Van Caeneghem Y; Laboratory for Experimental Immunology, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent 9000, Belgium.
  • Pourebrahim R; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Ma C; Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
  • Ni Z; Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
  • Garate Z; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA; Differentiation and Cytometry Unit, Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientale
  • Crane AM; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Li XS; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Liao W; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Gonzalez-Garay M; Center for Molecular Imaging, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA.
  • Segovia JC; Differentiation and Cytometry Unit, Hematopoietic Innovative Therapies Division, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) - Centro de Investigaciones Biomédicas en Red de Enfermedades Raras (CIBERER), Madrid 28040, Spain; Advanced Therapies Mixed Unit, Institut
  • Paschon DE; Sangamo BioSciences Inc, Richmond, CA 94804, USA.
  • Rebar EJ; Sangamo BioSciences Inc, Richmond, CA 94804, USA.
  • Holmes MC; Sangamo BioSciences Inc, Richmond, CA 94804, USA.
  • Kaufman D; Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
  • Vandekerckhove B; Laboratory for Experimental Immunology, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent 9000, Belgium.
  • Davis BR; Center for Stem Cell and Regenerative Medicine, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center, Houston, TX 77030, USA. Electronic address: brian.r.davis@uth.tmc.edu.
Stem Cell Reports ; 7(2): 139-48, 2016 08 09.
Article em En | MEDLINE | ID: mdl-27396937

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Terapia Genética / Linfopoese / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Wiskott-Aldrich / Terapia Genética / Linfopoese / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
...